BSEINDIA
BSE SENSEX
|
(Indicative Close)
Get Quote
    Corporate Announcement
    Security Code : 539871    Company : THYROCARE    
     
    Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2025, And Recommendation Of The Final Dividend, If Any, For The Financial Year 2024-25.Download PDF 0.53 MBDownload XBRL
      Exchange Received Time  15/04/2025 21:26:24         Exchange Disseminated Time   15/04/2025 21:26:24              Time Taken   00:00:00
    Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and to recommend the final dividend, if any, for the financial year 2024-25.
     

    Disclaimer

    Back To Announcements